Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
about
Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trialA Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskSelenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) studyCarotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.Suboptimal Plasma Long Chain n-3 Concentrations are Common among Adults in the United States, NHANES 2003-2004.Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study.Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree.Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk.A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer.Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placeboMyristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice.Association between omega-3 fatty acids and serum prostate-specific antigen.
P2860
Q28820954-481902A9-439C-427C-A1F2-FE7ECA8086B1Q31049602-3C84874F-6A88-4EB0-A768-2F46077F2516Q31112967-56EABDE3-47DF-42D5-9D77-6DD4CBA6AB3DQ35815985-20FF029A-5155-4F29-B2EC-D187D991F84AQ35957484-46D84361-472A-4A45-8F6E-CB9D5E6DFFB9Q36223045-3502A209-5B61-4189-9A41-2702E0A4B06AQ36401339-8FB780C5-9BAF-43FF-BC1D-45885246F267Q37368396-67EE1AA7-58BB-4D9E-A97E-F5BD58EF78F4Q38826821-62FF9B55-0AFF-4054-84E1-024EB4C34AEDQ39686200-097A5E43-258C-4AE9-A5FF-ECA4997C47B6Q46331253-0D34B1A7-D628-4118-B78D-59B55B6F1C12Q47565810-7E4DCF64-3501-46F7-94C2-14A28AC056ECQ47758380-D34C7151-EEC8-4C33-AC87-CE3CFD670687Q50433567-0715F517-F6B0-47A5-822A-5C6E77D9610E
P2860
Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Circulating fatty acids and pr ...... alysis of prospective studies.
@ast
Circulating fatty acids and pr ...... alysis of prospective studies.
@en
Circulating fatty acids and pr ...... alysis of prospective studies.
@nl
type
label
Circulating fatty acids and pr ...... alysis of prospective studies.
@ast
Circulating fatty acids and pr ...... alysis of prospective studies.
@en
Circulating fatty acids and pr ...... alysis of prospective studies.
@nl
prefLabel
Circulating fatty acids and pr ...... alysis of prospective studies.
@ast
Circulating fatty acids and pr ...... alysis of prospective studies.
@en
Circulating fatty acids and pr ...... alysis of prospective studies.
@nl
P2093
P2860
P31
P50
P356
P1476
Circulating fatty acids and pr ...... alysis of prospective studies.
@en
P2093
Alan R Kristal
Catherine M Tangen
Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
Francesca L Crowe
Gary E Goodman
Irena B King
Jorge E Chavarro
Lawrence N Kolonel
Lynne R Wilkens
Maria-Dolores Chirlaque
P2860
P356
10.1093/JNCI/DJU240
P407
P50
P577
2014-09-10T00:00:00Z